MiR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells

Mol Cell Biochem. 2014 May;390(1-2):155-60. doi: 10.1007/s11010-014-1966-x. Epub 2014 Jan 29.

Abstract

MicroRNAs play critical roles in the development and progression of non-small cell lung cancer (NSCLC). miR-96 acts as an oncogene in some malignancies, while its role in NSCLC is unclear. Here, we validated that miR-96 was significantly increased in both human NSCLC tissues and cell lines. Inhibition of miR-96 expression remarkably reduced cell proliferation, colony formation, migration, and invasion of NSCLC cells. Reversion-inducing-cysteine-rich protein with kazal motifs (RECK) was identified as a target of miR-96 in NSCLC cells. In addition, the expression of RECK was found to be negatively correlated with the expression of miR-96 in NSCLC tissues. Our data suggest that miR-96 might promote the growth and motility of NSCLC cells partially by targeting RECK.

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / genetics*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation*
  • GPI-Linked Proteins / biosynthesis*
  • GPI-Linked Proteins / genetics
  • Gene Expression Regulation, Neoplastic
  • Humans
  • MicroRNAs / genetics*

Substances

  • GPI-Linked Proteins
  • MIRN96 microRNA, human
  • MicroRNAs
  • RECK protein, human